Why TRT Raised Your Blood Pressure (and How to Fix It)

May 20, 2026
Why TRT Raised Your Blood Pressure (and How to Fix It)

Your cardiovascular system is a pressure system, and pressure systems care about two things: how much fluid is moving through them and how much resistance that fluid meets on the way through.

Testosterone affects both of those things, which is why blood pressure changes are one of the more common complaints from men who go on TRT. But "TRT raises blood pressure" is too simple to be useful, because the mechanism driving the increase determines the fix, and there are at least three separate mechanisms at work, each responding to a different intervention.

Start with the full picture so the pieces make sense when you zoom in.

When you introduce exogenous testosterone, your body responds by producing more red blood cells, converting some of that testosterone into estrogen, and expanding your total blood volume. Each of those responses can push blood pressure up independently. But managed correctly, none of them have to. And there is a study of 737 men on long-term testosterone where the men not already on blood pressure medication saw their systolic blood pressure drop about 12.5 points over time, which tells you that the hormone itself is not the problem.

The first mechanism, and the one with the clearest dose-response relationship, runs through something called erythropoiesis, which is the process your body uses to make new red blood cells. Testosterone signals the kidneys to produce more erythropoietin, which is a hormone that tells your bone marrow to ramp up red blood cell production. The more testosterone you take, the stronger that signal gets. A 2008 study showed that hemoglobin and hematocrit increased in a linear, dose-dependent way across graded testosterone doses in both young and older men, meaning there is no threshold effect here, it scales with your dose.

The problem this creates is a viscosity problem. More red blood cells means thicker blood, and thicker blood creates more resistance as it moves through your vessels. Think of it like the difference between pumping water through a pipe versus pumping syrup. The pump has to work harder, and in your body, that harder work shows up as elevated blood pressure.

A randomized controlled trial published in 2024 quantified exactly how much this matters. Men on testosterone whose hematocrit rose by more than 6% saw a 13.2 mmHg increase in systolic blood pressure compared to placebo. That is not a small number. For reference, most blood pressure medications are designed to lower systolic pressure by 10 to 15 mmHg, so an unmanaged hematocrit response can erase the benefit of an entire drug class.

The clinical threshold most used in practice is a hematocrit of 54%, and European Urology Focus published a management framework in 2023 recommending dose reduction or discontinuation above that number. Checking hematocrit every six months on TRT is not precautionary, it is how you catch this before it becomes a cardiovascular problem.

The second mechanism runs through estrogen, and this is where a lot of clinics accidentally make things worse.

Testosterone does not stay testosterone. Some of it converts into estradiol through a process called aromatization, which is carried out by an enzyme called aromatase found in fat tissue, the liver, and the brain. Estradiol at elevated levels causes sodium and water retention through effects on the renal tubules, which expands your blood volume and pushes pressure up. A 2005 study confirmed that testosterone independently increases extracellular water through exactly this kind of renal tubule effect.

The intuitive response is to block aromatase, and many clinics prescribe aromatase inhibitors routinely. But this creates a second problem, because estradiol is not just a side effect of testosterone therapy, it plays an active role in cardiovascular protection, endothelial function, and lipid metabolism. When you crush estradiol with an aromatase inhibitor, you remove that protection, and animal research has shown that aromatase inhibition increases mean arterial pressure and markers of kidney injury. So you can drive blood pressure up from the high estradiol direction and you can drive it up from the low estradiol direction, which means the goal is not to minimize estradiol, the goal is to keep it in range.

Most clinicians target a sensitive estradiol level between 20 and 40 pg/mL. The most reliable way to move it there is by adjusting injection frequency rather than adding a drug. More frequent injections of the same weekly dose create smaller hormonal peaks, which means less aromatization happens at any given moment, which means less estradiol accumulates.

The third mechanism is the one that has nothing to do with your blood values.

TRT increases blood volume. That is simply what it does, and the cardiovascular system adapts to increased volume through something called cardiac remodeling, which is the process by which the heart and vessels adjust their structure to accommodate the new demand. That adaptation works much better when you are training it to work better, meaning aerobic exercise is not optional on TRT from a cardiovascular standpoint.

Cardio improves your heart's stroke volume, which is how much blood it can move per beat, and it improves vascular compliance, which is how well your vessels expand and contract to buffer pressure changes. Without that, your system is running higher volume through a vascular structure that has not been trained to handle it, and the pressure reflects that.

So the three levers are hematocrit management checked every six months and kept under 54%, estradiol management through injection frequency before reaching for an AI, and aerobic training as a non-negotiable part of the protocol.

What is worth sitting with is what those 737 men in the long-term study actually represent. They were not men who avoided cardiovascular effects by staying on low doses or skipping TRT. They were men on testosterone therapy whose protocols were managed well, and their blood pressure went down. The hormone was not working against their cardiovascular system. The hormone was supporting it once the three mechanisms were no longer running unchecked.

TRT does not raise blood pressure. Unmanaged TRT raises blood pressure. Those are different problems with different solutions.


References

  1. Olesen TB, Glintborg D, Johnk F, et al. 2024. Blood pressure responses to testosterone therapy are amplified by hematocrit levels in opioid-induced androgen deficiency. Journal of Hypertension, 423, 531-540. Finding: Office SBP increased 6.2 mmHg in testosterone group vs 7.0 mmHg decrease in placebo net 13.2 mmHg. Men with hematocrit rise >6% saw clinically relevant BP increases. Source
  2. Coviello AD, Kaplan B, Lakshman KM, et al. 2008. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. Journal of Clinical Endocrinology and Metabolism, 933, 914-919. Finding: Hemoglobin and hematocrit increased in a linear, dose-dependent fashion. Source
  3. Almutlaq RN, Newell-Fugate AE, Evans LC, et al. 2022. Aromatase inhibition increases blood pressure and markers of renal injury in female rats. American Journal of Physiology Renal Physiology, 3232, F170-F181. Finding: Blocking aromatase increased mean arterial pressure. Source
  4. Hackett G, Mann A, Haider A, et al. 2024. Testosterone replacement therapy: effects on blood pressure in hypogonadal men. World Journal of Mens Health, 422, 431-443. Finding: Long-term TRT associated with significant SBP and DBP reductions. 33 of 202 men on antihypertensives discontinued them. Source
  5. Agrawal P, Singh SM, Kohn T. 2023. Management of erythrocytosis in men receiving testosterone therapy. European Urology Focus, 91, 139-142. Finding: Hematocrit >54% requires dose decrease or discontinuation. Source
  6. Johannsson G, Gibney J, Wolthers T, et al. 2005. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. Journal of Clinical Endocrinology and Metabolism, 907, 3891-3896. Finding: Testosterone independently increased extracellular water through renal tubule effects. Source

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness

If this is the kind of information you want access to on a daily basis, the community is free and there are full courses on training, nutrition, hormones, and supplementation inside. You can ask questions and post your own labs and get feedback from me and from the community.